株式会社Veritas In Silico Logo

株式会社Veritas In Silico

130A | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
品川区西五反田一丁目11番1号
Sector:
Health Care
Industry:
Pharmaceuticals

Description

株式会社Veritas In Silico is a pioneering Japanese biotechnology company focused on the development of innovative low molecular weight pharmaceuticals targeting mRNA and nucleic acids. Established in Tokyo, the company is committed to advancing drug discovery through cutting-edge research and strategic collaborations with leading pharmaceutical firms such as Takeda and Mitsubishi Gas Chemical. Veritas In Silico leverages its proprietary technologies to create novel therapeutic solutions, aiming to address unmet medical needs in various diseases. The company has recently gained attention for its growth potential and is actively engaged in partnerships to enhance its drug development pipeline. With a vision for a healthier future, Veritas In Silico aspires to transform the landscape of modern medicine.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-03-28 05:18
Inside Information Statement
臨時報告書
Japanese 27.1 KB
2025-03-28 02:47
Internal Control over Financial Reporting
内部統制報告書-第9期(2024/01/01-2024/12/31)
Japanese 22.5 KB
2025-03-28 02:47
Regulatory News Service
確認書
Japanese 8.8 KB
2025-03-28 02:46
Annual Report
有価証券報告書-第9期(2024/01/01-2024/12/31)
Japanese 3.1 MB
2024-08-14 08:00
Regulatory News Service
確認書
Japanese 8.7 KB
2024-08-14 08:00
Interim Report
半期報告書-第9期(2024/01/01-2024/12/31)
Japanese 171.1 KB
2024-05-15 09:55
Regulatory News Service
確認書
Japanese 8.7 KB
2024-05-15 08:00
Quarterly Report
四半期報告書-第9期第1四半期(2024/01/01-2024/03/31)
Japanese 146.8 KB
2024-03-15 07:01
Inside Information Statement
臨時報告書
Japanese 23.2 KB
2024-03-15 07:00
Annual Report
有価証券報告書-第8期(2023/01/01-2023/12/31)
Japanese 3.1 MB
2024-02-08 01:05
Inside Information Statement
臨時報告書
Japanese 21.1 KB
2024-01-31 07:00
Regulatory News Service
訂正有価証券届出書(新規公開時)
Japanese 2.4 MB
2024-01-23 07:00
Regulatory News Service
訂正有価証券届出書(新規公開時)
Japanese 2.4 MB
2024-01-05 07:00
Prospectus
有価証券届出書(新規公開時)
Japanese 5.0 MB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
MorphoSys AG Logo MorphoSys AG Germany MOR
MPH Health Care Logo MPH Health Care Germany 93M1
MUROMACHI CHEMICALS INC. Logo MUROMACHI CHEMICALS INC. Japan 4885
NANO MRNA Co.,Ltd. Logo NANO MRNA Co.,Ltd. Japan 4571
NATAC Logo NATAC Spain NAT
Navamedic Logo Navamedic Norway NAVA
Newbury Pharmaceuticals AB Logo Newbury Pharmaceuticals AB Sweden NEWBRY
New Nordic Healthbrands AB Logo New Nordic Healthbrands AB Sweden NNH
Nicoccino Holding AB Logo Nicoccino Holding AB Sweden NICO
Nicox S.A. Logo Nicox S.A. France COX